Skip to main content
Full access
LETTER
Published Online: 1 January 2008

Late-Life Anxiety

Publication: The Journal of Neuropsychiatry and Clinical Neurosciences
To the Editor: Anxiety disorders often begin in early adulthood 1 and an initial onset of these disorders after the age of 60 is usually associated with a traumatic event. 2 Numerous factors can predispose this population to high levels of anxiety, including medical illness, psychosocial changes, depression, and dementia. 1, 3 The symptoms are similar to those in younger patients, 1, 4 but they are usually associated with unfavorable prognosis in the elderly. 1
Anxiety disorders in the elderly are often underdiagnosed and, when treatment is provided, benzodiazepines are overused and antidepressants are underused. 5
The use of benzodiazepines is usually effective but is associated with increased risk of cognitive impairment, sedation, falls, and fractures. 6 Based on the safety, efficacy, and high rate of comorbid depression, 4 the serotonergic antidepressant medications are preferred to benzodiazepines as a first-line of treatment for anxiety disorders in the elderly. 6 Psychotherapy, particularly cognitive behavior therapy, is often effective in these disorders as well. 6
We reviewed symptoms of three cases in which onset of anxiety symptoms developed after age 60 as a result of having a medical procedure. They were highly functioning individuals and anxiety symptoms led to impairment of their social and occupational life. They were all successfully treated with selective serotonin reuptake inhibitor medications without any side effects and achieved the overall level of functioning.
The first case was a 61-year-old male who worked in graphic art. He developed severe neck pains and a magnetic resonance imaging scan (MRI) of cervical spines was recommended. After having the MRI, he developed recurrent unexpected panic attacks and anxiety about being in a closed place. Commuting to work caused marked distress and he subsequently avoided traveling in a bus, train, or car, and his daily activities were restricted. He initially refused to consider any medications that might limit his creativity. He agreed to a trial of sertraline, 50 mg/day, which was increased gradually to 100 mg. He noted significant improvement in intensity and frequency of his panic attacks and regained the ability to use the public transportation without any fear.
The second case involved a 61-year-old female who was a medical technician.
She suffered gastrointestinal reflux disease and underwent diagnostic upper endoscopy. Since then, she had been feeling anxious, and had poor concentration, frequent unpredicted panic attacks, and anxiety about being in a crowd. She could not resume her work and preferred to stay home to avoid situations that might provoke her anxiety. She was prescribed sertraline and was maintained on 150 mg/day. She reported lower anxiety level, became comfortable in public, and decided to look for a part-time job.
The third case was a 75-year-old male. He was a retired photographer and developed minor neurological deficits. Computed tomography scan (CT) of the head was conducted. After the image study, he started to have periods of intense fear and excessive worry cued by his presence in places from which escape might be difficult. He isolated himself at home, stopped going to church services and the senior citizen center, and suffered depression. He showed significant symptom response on paroxetine, 40 mg/day.

References

1.
Sadock BJ, Sadock VA: Geriatric psychiatry, in Kaplan and Sadock’s Synopsis of Psychiatry: Behavioral Sciences/ Clinical Psychiatry, 9th ed. Philadelphia, Lippincott, Williams & Wilkins, 2002, pp 1318–1337
2.
Flint AJ: Management of anxiety in late life. J Geriatr Psychiatr Neurol 1998; 11:194–200
3.
Rangaraj J, Pelissolo A: Anxiety disorders in the elderly: clinical and therapeutic aspects. Psychol Neuropsychiatr Vieil 2006; 4:179–187
4.
Flint AJ, Gagnon N: Diagnosis and management of panic disorder in older patients. Drugs Aging 2003; 20:881–891
5.
Flint AJ: Epidemiology and comorbidity of anxiety disorders in later life: implications for treatment. Clin Neurosci 1997; 4:31–36
6.
Lenze EJ, Pollock BG, Shear MK, et al: Treatment considerations for anxiety in the elderly. CNS Spectr 2003; 8(S3):6–13

Information & Authors

Information

Published In

Go to The Journal of Neuropsychiatry and Clinical Neurosciences
Go to The Journal of Neuropsychiatry and Clinical Neurosciences
The Journal of Neuropsychiatry and Clinical Neurosciences
Pages: 116 - 117
PubMed: 18305303

History

Published online: 1 January 2008
Published in print: Winter, 2008

Authors

Details

Nahla A. Mahgoub, M.D.
Psychiatry, Weill Medical College of Cornell University, New York
Jahandar Saifollahi, M.D.
Melinda Lantz, M.D.
Geriatric Psychiatry, Beth Israel Medical Center, New York

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

PPV Articles - Journal of Neuropsychiatry and Clinical Neurosciences

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share